Smaller low-density lipoprotein size as a possible risk factor for the prevalence of coronary artery diseases in haemodialysis patients: Associations of cholesteryl ester transfer protein and the hepatic lipase gene polymorphism with low-density lipoprotein size

Nephrology

Volumn 16, Issue 6, 2011, Pages 558-566

  Kimura, Hideki ^a   Miyazaki, Ryoichi ^b   Imura, Toshio ^c   Masunaga, Shinya ^c   Shimada, Akihiro ^c   Mikami, Daisuke ^a   Kasuno, Kenji ^a   Takahashi, Naoki ^a   Hirano, Tsutomu ^d   Yoshida, Haruyoshi ^a  

^a UNIVERSITY OF FUKUI   (Japan)

^b Fujita Memorial Hospital   (Japan)

^c UNIVERSITY OF FUKUI HOSPITAL   (Japan)

^d SHOWA UNIVERSITY   (Japan)

Author keywords

cholesteryl ester transfer protein; coronary artery disease; haemodialysis; hepatic lipase gene polymorphism; low density lipoprotein size

Indexed keywords

CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIVER TRIACYLGLYCEROL LIPASE; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DNA POLYMORPHISM; FEMALE; GENOTYPE; HEMODIALYSIS PATIENT; HUMAN; HYPERTRIGLYCERIDEMIA; LIPID HYDROLYSIS; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MULTIPLE LINEAR REGRESSION ANALYSIS; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL; TRIACYLGLYCEROL LIPASE BLOOD LEVEL;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CHI-SQUARE DISTRIBUTION; CHOLESTEROL ESTER TRANSFER PROTEINS; CORONARY ARTERY DISEASE; FEMALE; GENOTYPE; HUMANS; JAPAN; LINEAR MODELS; LIPASE; LIPOPROTEINS, LDL; LIVER; LOGISTIC MODELS; MALE; MIDDLE AGED; PARTICLE SIZE; PHENOTYPE; POLYMORPHISM, GENETIC; PREVALENCE; RENAL DIALYSIS; RISK ASSESSMENT; RISK FACTORS; TRIGLYCERIDES;

EID: 80051699036     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2011.01454.x     Document Type: Article

References (32)

1. Held PJ, Port FK, Webb RL, et al,. Excerpts from United States Renal Data System 1995 Annual Data Report. Am. J. Kidney Dis. 1995; 26: S1-186.
2. Rostand SG, Brunzell JD, Cannon RO 3rd, Victor RG,. Cardiovascular complications in renal failure. J. Am. Soc. Nephrol. 1991; 2: 1053-62.
3. Becker BN, Himmelfarb J, Henrich WL, Hakim RM,. Reassessing the cardiac risk profile in chronic hemodialysis patients: A hypothesis on the role of oxidant stress and other non-traditional cardiac risk factors. J. Am. Soc. Nephrol. 1997; 8: 475-86. (Pubitemid 127454184)
4. Shoji T, Nishizawa Y, Nishitani H, Yamakawa M, Morii H,. Impaired metabolism of high density lipoprotein in uremic patients. Kidney Int. 1992; 41: 1653-61.
5. Krane V, Wanner C,. The metabolic burden of diabetes and dyslipidaemia in chronic kidney disease. Nephrol. Dial. Transplant. 2002; 17 (Suppl 11): 23-7. (Pubitemid 35277059)
6. Ritz E, Wanner C,. Lipid abnormalities and cardiovascular risk in renal disease. J. Am. Soc. Nephrol. 2008; 19: 1065-70.
7. Hirano T, Ito Y, Yoshino G,. Measurement of small dense low-density lipoprotein particles. J. Atheroscler. Thromb. 2005; 12: 67-72.
8. Chapman MJ, Guerin M, Bruckert E,. Atherogenic, dense low-density lipoproteins. Pathophysiology and new therapeutic approaches. Eur. Heart J. 1998; 19 (Suppl A): A24-30. (Pubitemid 28112474)
9. Carmena R, Duriez P, Fruchart JC,. Atherogenic lipoprotein particles in atherosclerosis. Circulation 2004; 109: III2-7. (Pubitemid 38786436)
10. Koba S, Hirano T, Yoshino G, et al,. Remarkably high prevalence of small dense low-density lipoprotein in Japanese men with coronary artery disease, irrespective of the presence of diabetes. Atherosclerosis 2002; 160: 249-56. (Pubitemid 34076661)
11. Vakkilainen J, Steiner G, Ansquer JC, et al,. Relationships between low-density lipoprotein particle size, plasma lipoproteins, and progression of coronary artery disease: The Diabetes Atherosclerosis Intervention Study (DAIS). Circulation 2003; 107: 1733-7. (Pubitemid 36418352)
12. Moon JY, Kwon HM, Kwon SW, et al,. Lipoprotein(a) and LDL particle size are related to the severity of coronary artery disease. Cardiology 2007; 108: 282-9. (Pubitemid 350126472)
13. Gardner CD, Fortmann SP, Krauss RM,. Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women. JAMA 1996; 276: 875-81. (Pubitemid 26301606)
14. Morton RE,. Cholesteryl ester transfer protein and its plasma regulator: Lipid transfer inhibitor protein. Curr. Opin. Lipidol. 1999; 10: 321-7. (Pubitemid 29419689)
15. Carr MC, Ayyobi AF, Murdoch SJ, Deeb SS, Brunzell JD,. Contribution of hepatic lipase, lipoprotein lipase, and cholesteryl ester transfer protein to LDL and HDL heterogeneity in healthy women. Arterioscler. Thromb. Vasc. Biol. 2002; 22: 667-73. (Pubitemid 34408751)
16. Vakkilainen J, Jauhiainen M, Ylitalo K, et al,. LDL particle size in familial combined hyperlipidemia: Effects of serum lipids, lipoprotein-modifying enzymes, and lipid transfer proteins. J. Lipid. Res. 2002; 43: 598-603.
17. Tall AR,. Plasma cholesteryl ester transfer protein. J. Lipid. Res. 1993; 34: 1255-74. (Pubitemid 23230305)
18. Thuren T,. Hepatic lipase and HDL metabolism. Curr. Opin. Lipidol. 2000; 11: 277-83. (Pubitemid 30336025)
19. Hogue JC, Lamarche B, Gaudet D, et al,. Relationship between cholesteryl ester transfer protein and LDL heterogeneity in familial hypercholesterolemia. J. Lipid. Res. 2004; 45: 1077-83. (Pubitemid 38679503)
20. Kimura H, Miyazaki R, Imura T, et al,. Hepatic lipase mutation may reduce vascular disease prevalence in hemodialysis patients with high CETP levels. Kidney Int. 2003; 64: 1829-37. (Pubitemid 37323714)
21. Hirano T, Oi K, Sakai S, Kashiwazaki K, Adachi M, Yoshino G,. High prevalence of small dense LDL in diabetic nephropathy is not directly associated with kidney damage: A possible role of postprandial lipemia. Atherosclerosis 1998; 141: 77-85. (Pubitemid 28539418)
22. Ambrosch A, Domroese U, Westphal S, et al,. Compositional and functional changes of low-density lipoprotein during hemodialysis in patients with ESRD. Kidney Int. 1998; 54: 608-17. (Pubitemid 28357425)
23. Oi K, Hirano T, Sakai S, Kawaguchi Y, Hosoya T,. Role of hepatic lipase in intermediate-density lipoprotein and small, dense low-density lipoprotein formation in hemodialysis patients. Kidney Int. Suppl. 1999; 71: S227-8. (Pubitemid 29304859)
24. Quaschning T, Schomig M, Keller M, et al,. Non-insulin-dependent diabetes mellitus and hypertriglyceridemia impair lipoprotein metabolism in chronic hemodialysis patients. J. Am. Soc. Nephrol. 1999; 10: 332-41. (Pubitemid 29068073)
25. Yeo Y, Byun SW, Lee JY, Min WK, Park JS, Kim SB,. Lack of Association between small dense low-density lipoprotein levels and coronary artery disease in chronic hemodialysis patients. Am. J. Nephrol. 2009; 30: 310-14.
26. Cohn JS, McNamara JR, Cohn SD, Ordovas JM, Schaefer EJ,. Postprandial plasma lipoprotein changes in human subjects of different ages. J. Lipid. Res. 1988; 29: 469-79.
27. Kimura H, Miyazaki R, Suzuki S, Gejyo F, Yoshida H,. Cholesteryl ester transfer protein as a protective factor against vascular disease in hemodialysis patients. Am. J. Kidney Dis. 2001; 38: 70-6. (Pubitemid 32611761)
28. Arai H, Yamamoto A, Matsuzawa Y, et al,. Polymorphisms in four genes related to triglyceride and HDL-cholesterol levels in the general Japanese population in 2000. J. Atheroscler. Thromb. 2005; 12: 240-50.
29. Prichard SS,. Impact of dyslipidemia in end-stage renal disease. J. Am. Soc. Nephrol. 2003; 14: S315-20. (Pubitemid 37052397)
30. St-Pierre AC, Cantin B, Dagenais GR, et al,. Low-density lipoprotein subfractions and the long-term risk of ischemic heart disease in men: 13-year follow-up data from the Quebec Cardiovascular Study. Arterioscler. Thromb. Vasc. Biol. 2005; 25: 553-9. (Pubitemid 40315677)
31. Koba S, Tsunoda F, Hirano T, et al,. Postprandial changes in LDL phenotypes in patients with myocardial infarction. Eur. J. Clin. Invest. 2005; 35: 171-9. (Pubitemid 40343882)
32. Kwan BC, Kronenberg F, Beddhu S, Cheung AK,. Lipoprotein metabolism and lipid management in chronic kidney disease. J. Am. Soc. Nephrol. 2007; 18: 1246-61. (Pubitemid 46536911)